Compound A concentration in the circle absorber system during low-flow sevoflurane anesthesia: Comparison of Drägersorb Free®, Amsorb®, and Sodasorb II®

Journal of Clinical Anesthesia

Volumn 15, Issue 1, 2003, Pages 33-37

  Kobayashi, Shunji ^a   Bito, Hiromichi ^a   Obata, Yukako ^a   Katoh, Takasumi ^a   Sato, Shigehito ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amsorb ; Anesthesia; Carbon dioxide absorbents; Compound A; Dr gersorb Free ; Low flow; Sevoflurane

Indexed keywords

ABSORBENT; SEVOFLURANE;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; GENERAL ANESTHESIA; HUMAN; INSPIRATORY CAPACITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNIVERSITY HOSPITAL;

EID: 0037301129     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(02)00478-6     Document Type: Article

References (24)

1. Morio M., Fujii K., Satoh N., et al. Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts. Anesthesiology. 77:1992;1155-1164.
2. Gonsowski C.T., Laster M.J., Eger E.I. 2nd, Ferrell L.D., Kerschmann R.L. Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology. 80:1994;556-565.
3. Gonsowski C.T., Laster M.J., Eger E.I. 2nd, Ferrell L.D., Kerschmann R.L. Toxicity of compound A in rats effect of increasing duration of administration . Anesthesiology. 80:1994;566-573.
4. Kharasch E.D., Thorning D., Garton K., Hankins D.C., Kilty C.G. Role of renal cysteine conjugate β-lyase in the mechanism of compound A nephrotoxicity in rats. Anesthesiology. 86:1997;160-171.
5. Kharasch E.D., Hoffman G.M., Thorning D., Hankins D.C., Kilty C.G. Role of the renal cysteine conjugate β-lyase pathway in inhaled compound A nephrotoxicity in rats. Anesthesiology. 88:1998;1624-1633.
6. Mazze R.I., Jamison R.L. Low-flow (1 l/min) sevoflurane is it safe? Anesthesiology. 86:1997;1225-1227.
7. Eger E.I. 2nd, Koblin D.D., Bowland T., et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg. 84:1997;160-168.
8. Ebert T.J., Frink E.J. Jr, Kharasch E.D. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology. 88:1998;601-610.
9. Higuchi H., Sumita S., Wada H., et al. Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity. Anesthesiology. 89:1998;307-322.
10. Obata R., Bito H., Ohmura M., et al. The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function. Anesth Analg. 91:2000;1262-1268.
11. ® degradation of volatile anesthetics and formation of carbon monoxide and compound A in swine in vivo. Anesthesiology. 96:2002;173-182.
12. Murray J.M., Renfrew C.W., Bedi A., McCrystal C.B., Jones D.S., Fee J.P. Amsorb a new carbon dioxide absorbent for use in anesthetic breathing systems . Anesthesiology. 91:1999;1342-1348.
13. Stabernack C.R., Brown R., Laster M.J., Dudziak R., Eger E.I. 2nd. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide. Anesth Analg. 90:2000;1428-1435.
14. Yamakage M., Yamada S., Chen X., Iwasaki S., Tsujiguchi N., Namiki A. Carbon dioxide absorbents containing potassium hydroxide produce much larger concentrations of compound A from sevoflurane in clinical practice. Anesth Analg. 91:2000;220-224.
15. Higuchi H., Adachi Y., Arimura S., Kanno M., Satoh T. Compound A concentrations during low-flow sevoflurane anesthesia correlate directly with the concentration of monovalent bases in carbon dioxide absorbents. Anesth Analg. 91:2000;434-439.
16. Baum J., van Aken H. Calcium hydroxide lime-a new carbon dioxide absorbent a rationale for judicious use of different absorbents . Eur J Anaesthesiol. 17:2000;597-600.
17. Mchaourab A., Arain S.R., Ebert T.J. Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans. Anesthesiology. 94:2001;1007-1009.
18. Versichelen L.F., Bouche M.P., Rolly G., et al. Only carbon dioxide absorbents free of both NaOH and KOH do not generate compound A during in vitro closed-system sevoflurane. Anesthesiology. 95:2001;750-755.
19. 2 absorbent on compound A production in vitro. Anesthesiology. 91:1999;A400.
20. Cunningham D.D., Huang S., Webster J., Mayoral J., Grabenkort R.W. Sevoflurane degradation to compound A in anaesthesia breathing systems. Br J Anaesth. 77:1996;537-543.
21. 2 absorbent in a standard anesthetic circuit. J Anesth. 14:2000;143-146.
22. Bito H., Ikeda K. Effect of total flow on the concentration of degradation products generated by reaction between sevoflurane and soda lime. Br J Anaesth. 74:1995;667-669.
23. Lentz R. CO poisoning during anesthesia poses puzzles. Anesth Patient Safety Foundation News. 9:1994;13-14.
24. Fang Z.X., Eger E.I. 2nd, Laster M.J., Chortkoff B.S., Kandel L., Ionescu P. Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme. Anesth Analg. 80:1995;1187-1193.